Lightchain Capital

Recent News

Logo-Geneoscopy-400
March 10, 2023

Geneoscopy Joins White House for Cancer Moonshot Colorectal Cancer Forum

READ MORE
CareVet-Logo-New
March 09, 2023

CareVet Expands Carebnb, Offering More Paid Vacation Opportunities for Veterinarians

READ MORE
Logo-Geneoscopy-400
March 07, 2023

Health Tech: Erica Barnell On How Geneoscopy's Technology Can Make An Important Impact On Our Overall Wellness

READ MORE
Logo-Geneoscopy-400
February 28, 2023

Geneoscopy appoints Don Hardison to its Board of Directors

READ MORE
Logo-Geneoscopy-Full
January 24, 2023

Geneoscopy Submits Premarket Approval Application to FDA for its Noninvasive Colorectal Cancer RNA Biomarker Screening Test

READ MORE
Logo-Geneoscopy-400
January 10, 2023

Geneoscopy’s Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and Specificity in Large Pivotal Clinical Trial

READ MORE
aiProteins_Final_logo300
December 14, 2022

AI Proteins Expands Executive Team with Hire of Industry Veteran Wendy Dwyer as Chief Business Officer

READ MORE
Logo-Geneoscopy-400
December 13, 2022

Geneoscopy Receives Accreditation from the College of American Pathologists (CAP) for its St. Louis Clinical Laboratory

READ MORE
Logo-Geneoscopy-400
December 13, 2022

Geneoscopy Receives Accreditation from the College of American Pathologists (CAP) for its St. Louis Clinical Laboratory

READ MORE
NextRNA-Logo-FullColor-400
December 08, 2022

NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2021 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group